A New Dancing Partner for Venetoclax: Gilteritinib

J Clin Oncol. 2022 Dec 10;40(35):4033-4036. doi: 10.1200/JCO.22.01386. Epub 2022 Sep 2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aniline Compounds*
  • Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
  • Humans
  • Sulfonamides / therapeutic use

Substances

  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic
  • gilteritinib
  • Aniline Compounds
  • Sulfonamides